Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Name:	us-gaap_DilutiveSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Loss per share attributable to CVSL (Details) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
Loss per share attributable to CVSL (Details) (USD $)	Jun. 30, 2013	Jun. 30, 2011	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013	Dec. 31, 2012	Jun. 30, 2014 Rochon Capital	Dec. 31, 2013 Rochon Capital	Apr. 10, 2013 Rochon Capital
Loss per share attributable to CVSL
Adjustments to net earnings	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
Loss per share attributable to CVSL
Number of additional shares available for issuance included in the calculation of basic and diluted shares							504,813,512	504,813,512	504,813,514